Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. (Q52305239)

29 April 2018

title

Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. (English)

1 reference

29 April 2018

1 reference

9

1 reference

29 April 2018

Giuseppe Nappi

7

Giuseppe Nappi

1 reference

29 April 2018

6

Cristina Tassorelli

1 reference

29 April 2018

2

Michele Viana

1 reference

29 April 2018

Pier Luigi Canonico

8

Pier Luigi Canonico

1 reference

29 April 2018

Salvatore Terrazzino

10

Salvatore Terrazzino

1 reference

29 April 2018

Sarah Cargnin

1

Sarah Cargnin

1 reference

29 April 2018

Natascia Ghiotto

5

Natascia Ghiotto

1 reference

29 April 2018

author name string

Grazia Sances

3

1 reference

29 April 2018

Marika Bianchi

4

1 reference

29 April 2018

publication date

7 August 2014

1 reference

29 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

29 April 2018

volume

70

1 reference

29 April 2018

page(s)

1195-1202

1 reference

29 April 2018

issue

10

1 reference

29 April 2018

https://scigraph.springernature.com/pub.10.1007/s00228-014-1726-6

exact match

0 references

cites work

Medication-overuse headache: a worldwide problem

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Clinical features, pathophysiology, and treatment of medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Cost of disorders of the brain in Europe 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The cost of headache disorders in Europe: the Eurolight project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

A narrative review on the management of medication overuse headache: the steep road from experience to evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Probable medication-overuse headache: the effect of a 2-month drug-free period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Medication-overuse headache: similarities with drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The influence of gene-environment interactions on the development of alcoholism and drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Association analysis of the DRD4 and COMT genes in methamphetamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Impulsive traits and 5-HT2A receptor promoter polymorphism in alcohol dependents: possible association but no influence of personality disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

SNPStats: a web tool for the analysis of association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Role of 2 common variants of 5HT2A gene in medication overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Drug-dependence behaviour and outcome of medication-overuse headache after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The International Classification of Headache Disorders, 3rd edition (beta version)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Orbitofrontal dysfunction and medication overuse in patients with migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The orbital prefrontal cortex and drug addiction in laboratory animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Catechol-O-methyltransferase Val158Met polymorphism modulates gray matter volume and functional connectivity of the default mode network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

The dopamine D2 receptor gene DRD2 and the nicotinic acetylcholine receptor gene CHRNA4 interact on striatal gray matter volume: evidence from a genetic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1726-6

A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study

21 January 2018

1 reference

12 December 2020

Family history for chronic headache and drug overuse as a risk factor for headache chronification

1 reference

12 December 2020

Dopamine signaling in reward-related behaviors

1 reference

12 December 2020

The International Classification of Headache Disorders: 2nd edition

1 reference

12 December 2020

Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.

1 reference

12 December 2020

High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers.

1 reference

12 December 2020

Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control.

1 reference

12 December 2020

Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol).

1 reference

12 December 2020

10.1007/S00228-014-1726-6

Identifiers

DOI

1 reference

29 April 2018

PubMed ID

25096645

1 reference

29 April 2018